• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用韩国健康保险数据库研究合并症负担对 COVID-19 患者死亡率的影响。

Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database.

机构信息

Department of Dermatology, Seoul National University Hospital, Seoul, Republic of Korea.

Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

出版信息

Sci Rep. 2021 Mar 18;11(1):6375. doi: 10.1038/s41598-021-85813-2.

DOI:10.1038/s41598-021-85813-2
PMID:33737679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7973767/
Abstract

We aimed to investigate the impact of comorbidity burden on mortality in patients with coronavirus disease (COVID-19). We analyzed the COVID-19 data from the nationwide health insurance claims of South Korea. Data on demographic characteristics, comorbidities, and mortality records of patients with COVID-19 were extracted from the database. The odds ratios of mortality according to comorbidities in these patients with and without adjustment for age and sex were calculated. The predictive value of the original Charlson comorbidity index (CCI) and the age-adjusted CCI (ACCI) for mortality in these patients were investigated using the receiver operating characteristic (ROC) curve analysis. Among 7590 patients, 227 (3.0%) had died. After age and sex adjustment, hypertension, diabetes mellitus, congestive heart failure, dementia, chronic pulmonary disease, liver disease, renal disease, and cancer were significant risk factors for mortality. The ROC curve analysis showed that an ACCI threshold > 3.5 yielded the best cut-off point for predicting mortality (area under the ROC 0.92; 95% confidence interval 0.91-0.94). Our study revealed multiple risk factors for mortality in patients with COVID-19. The high predictive power of the ACCI for mortality in our results can support the importance of old age and comorbidities in the severity of COVID-19.

摘要

我们旨在探讨合并症负担对冠状病毒病 (COVID-19) 患者死亡率的影响。我们分析了来自韩国全国健康保险索赔的 COVID-19 数据。从数据库中提取了 COVID-19 患者的人口统计学特征、合并症和死亡率记录。计算了这些患者有无年龄和性别调整的合并症与死亡率之间的比值比。使用接收者操作特征 (ROC) 曲线分析,研究了原始 Charlson 合并症指数 (CCI) 和年龄调整的 CCI (ACCI) 对这些患者死亡率的预测价值。在 7590 名患者中,有 227 人 (3.0%) 死亡。在年龄和性别调整后,高血压、糖尿病、充血性心力衰竭、痴呆、慢性肺病、肝病、肾病和癌症是死亡的显著危险因素。ROC 曲线分析表明,ACCI 阈值 > 3.5 可预测死亡率的最佳截断点 (ROC 曲线下面积为 0.92;95%置信区间为 0.91-0.94)。我们的研究揭示了 COVID-19 患者死亡的多个危险因素。在我们的结果中,ACCI 对死亡率的高预测能力可以支持年龄和合并症在 COVID-19 严重程度中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/ef71483befd4/41598_2021_85813_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/77cf7aa0bb3b/41598_2021_85813_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/ace2c88acbdd/41598_2021_85813_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/4a58ae1878e4/41598_2021_85813_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/ef71483befd4/41598_2021_85813_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/77cf7aa0bb3b/41598_2021_85813_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/ace2c88acbdd/41598_2021_85813_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/4a58ae1878e4/41598_2021_85813_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abce/7973767/ef71483befd4/41598_2021_85813_Fig4_HTML.jpg

相似文献

1
Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database.利用韩国健康保险数据库研究合并症负担对 COVID-19 患者死亡率的影响。
Sci Rep. 2021 Mar 18;11(1):6375. doi: 10.1038/s41598-021-85813-2.
2
Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea.韩国基于人群的研究:2 型糖尿病合并 COVID-19 患者的临床结局。
Endocrinol Metab (Seoul). 2020 Dec;35(4):901-908. doi: 10.3803/EnM.2020.787. Epub 2020 Dec 10.
3
A Clinical Risk Score to Predict In-hospital Mortality from COVID-19 in South Korea.韩国用于预测 COVID-19 住院患者死亡率的临床风险评分
J Korean Med Sci. 2021 Apr 19;36(15):e108. doi: 10.3346/jkms.2021.36.e108.
4
Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study.年龄校正的查尔森合并症指数对鼻咽癌放疗后患者临床结局的有效性:一项为期5年的全国队列研究。
PLoS One. 2015 Jan 24;10(1):e0117323. doi: 10.1371/journal.pone.0117323. eCollection 2015.
5
COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea.免疫功能低下患者的 COVID-19 相关结局:韩国的一项全国性研究。
PLoS One. 2021 Oct 1;16(10):e0257641. doi: 10.1371/journal.pone.0257641. eCollection 2021.
6
Socioeconomic disparities in Korea by health insurance type during the COVID-19 pandemic: a nationwide study.韩国在 COVID-19 大流行期间按医疗保险类型划分的社会经济差异:一项全国性研究。
Epidemiol Health. 2021;43:e2021007. doi: 10.4178/epih.e2021007. Epub 2021 Jan 13.
7
Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study.韩国基础合并症对 COVID-19 感染和严重程度的影响:一项全国性病例对照研究。
J Korean Med Sci. 2020 Jun 29;35(25):e237. doi: 10.3346/jkms.2020.35.e237.
8
Frailty and comorbidity in predicting community COVID-19 mortality in the U.K. Biobank: The effect of sampling.衰弱和合并症对英国生物库社区 COVID-19 死亡率的预测:抽样的影响。
J Am Geriatr Soc. 2021 May;69(5):1128-1139. doi: 10.1111/jgs.17089. Epub 2021 Mar 5.
9
Impact of comorbid asthma on severity of coronavirus disease (COVID-19).合并哮喘对新型冠状病毒疾病(COVID-19)严重程度的影响。
Sci Rep. 2020 Dec 11;10(1):21805. doi: 10.1038/s41598-020-77791-8.
10
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症:一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.

引用本文的文献

1
Comparing major comorbidity indices as predictors of all-cause mortality in the Veterans Affairs health care system.比较主要共病指数作为退伍军人事务部医疗保健系统中全因死亡率预测指标的情况。
J Clin Epidemiol. 2025 Jun;182:111778. doi: 10.1016/j.jclinepi.2025.111778. Epub 2025 Apr 2.
2
The Role of COVID-19 in Excess Mortality in Slovakia: A Novel Approach Based on Healthcare Billing Records.新冠病毒在斯洛伐克超额死亡率中的作用:一种基于医疗计费记录的新方法。
Int J Public Health. 2024 Dec 3;69:1607537. doi: 10.3389/ijph.2024.1607537. eCollection 2024.
3
Assessing COVID-19 Vulnerability Among HIV-positive Men Who Have Sex With Men in Korea: The Role of Vaccination and Sexual Behaviors.

本文引用的文献

1
Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis.临床虚弱量表与 COVID-19 死亡率:系统评价和剂量反应荟萃分析。
Arch Gerontol Geriatr. 2021 Mar-Apr;93:104324. doi: 10.1016/j.archger.2020.104324. Epub 2020 Dec 15.
2
Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis.新冠肺炎患者Charlson 共病指数与不良结局综合指标的系统评价和荟萃分析。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2103-2109. doi: 10.1016/j.dsx.2020.10.022. Epub 2020 Oct 28.
3
Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study.
评估韩国男男性行为者中艾滋病毒阳性者感染新冠病毒的易感性:疫苗接种和性行为的作用
J Prev Med Public Health. 2024 Jul;57(4):370-378. doi: 10.3961/jpmph.24.196. Epub 2024 Jun 24.
4
The epidemiology and treatment outcomes of COVID-19 patients admitted to an intensive care unit in an Iranian hospital in Neyshabur city.内沙布尔市一家伊朗医院重症监护病房收治的新冠肺炎患者的流行病学情况及治疗结果
Health Sci Rep. 2024 Apr 22;7(4):e2049. doi: 10.1002/hsr2.2049. eCollection 2024 Apr.
5
Evaluation of comorbidities in the SARS-CoV-2-related mortalities: A retrospective observation from a dedicated COVID-19 care hospital.SARS-CoV-2相关死亡病例的合并症评估:来自一家专门的COVID-19护理医院的回顾性观察。
J Family Med Prim Care. 2024 Feb;13(2):585-588. doi: 10.4103/jfmpc.jfmpc_2404_22. Epub 2024 Mar 6.
6
Impact of the COVID-19 pandemic on mortality and loss to follow-up among patients with dementia receiving anti-dementia medications.COVID-19 大流行对接受抗痴呆药物治疗的痴呆症患者的死亡率和失访率的影响。
Sci Rep. 2024 Apr 5;14(1):7986. doi: 10.1038/s41598-024-58316-z.
7
The footprint of human-induced climate change on heat-related deaths in the summer of 2022 in Switzerland.2022年夏季人为引起的气候变化对瑞士与高温相关死亡的影响。
Environ Res Lett. 2023 Jul 4;18:074037. doi: 10.1088/1748-9326/ace0d0.
8
Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID‑19 in Northern Iran: a large cohort study.伊朗北部六波 COVID-19 期间住院患者的人口统计学、临床特征和结局:一项大型队列研究。
Sci Rep. 2023 Dec 18;13(1):22527. doi: 10.1038/s41598-023-50139-8.
9
Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis.COVID-19 疫苗接种前患有癌症的人群因 COVID-19 死亡的风险:系统评价和荟萃分析。
Int J Cancer. 2024 Apr 15;154(8):1394-1412. doi: 10.1002/ijc.34798. Epub 2023 Dec 11.
10
Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study.基于性别、合并症和社会经济地位的 COVID-19 疫苗成本效益分析:一项人群研究。
Pharmacoeconomics. 2024 Feb;42(2):219-229. doi: 10.1007/s40273-023-01326-y. Epub 2023 Nov 1.
韩国基础合并症对 COVID-19 感染和严重程度的影响:一项全国性病例对照研究。
J Korean Med Sci. 2020 Jun 29;35(25):e237. doi: 10.3346/jkms.2020.35.e237.
4
Public Health Emergency and Crisis Management: Case Study of SARS-CoV-2 Outbreak.突发公共卫生事件与危机管理:以 SARS-CoV-2 爆发为例
Int J Environ Res Public Health. 2020 Jun 4;17(11):3984. doi: 10.3390/ijerph17113984.
5
The effect of large-scale anti-contagion policies on the COVID-19 pandemic.大规模防疫政策对 COVID-19 大流行的影响。
Nature. 2020 Aug;584(7820):262-267. doi: 10.1038/s41586-020-2404-8. Epub 2020 Jun 8.
6
Clinical Presentation of COVID19 in Dementia Patients.COVID19 患者的临床特征。
J Nutr Health Aging. 2020;24(6):560-562. doi: 10.1007/s12603-020-1389-1.
7
The Delay in Confirming COVID-19 Cases Linked to a Religious Group in Korea.韩国与一个宗教团体相关的新冠确诊病例确认延迟。
J Prev Med Public Health. 2020 May;53(3):164-167. doi: 10.3961/jpmph.20.088. Epub 2020 Apr 8.
8
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).慢性阻塞性肺疾病与严重的2019冠状病毒病(COVID-19)相关。
Respir Med. 2020 Jun;167:105941. doi: 10.1016/j.rmed.2020.105941. Epub 2020 Mar 24.
9
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.COVID-19 患者的性别差异:关注严重程度和死亡率。
Front Public Health. 2020 Apr 29;8:152. doi: 10.3389/fpubh.2020.00152. eCollection 2020.
10
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.